Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease

Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe disease

BACKGROUND. Cross-reactive immunological material–negative (CRIM-negative) infantile Pompe disease (IPD) patients develop an immune response against enzyme replacement therapy (ERT) with alglucosidase alfa that nullifies ERT efficacy. Prophylactic immune tolerance induction (ITI) with rituximab, met...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kazi, Zoheb B., Desai, Ankit K., Berrier, Kathryn L., Troxler, R. Bradley, Wang, Raymond Y., Abdul-Rahman, Omar A., Tanpaiboon, Pranoot, Mendelsohn, Nancy J., Herskovitz, Eli, Kronn, David, Inbar-Feigenberg, Michal, Ward-Melver, Catherine, Polan, Michelle, Gupta, Punita, Rosenberg, Amy S., Kishnani, Priya S.
Médium: Text
Jazyk:angličtina
Vydáno: American Society for Clinical Investigation 2017
Témata:
Clinical Medicine
On-line přístup:https://pmc.ncbi.nlm.nih.gov/articles/PMC5621909/
https://pubmed.ncbi.nlm.nih.gov/28814660
http://dx.doi.org/10.1172/jci.insight.94328
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC5621909/
https://pubmed.ncbi.nlm.nih.gov/28814660
http://dx.doi.org/10.1172/jci.insight.94328

Podobné jednotky